TAPAZOL

This brand name is authorized in Brazil, Ecuador, Mexico

Active ingredients

The drug TAPAZOL contains one active pharmaceutical ingredient (API):

1 Thiamazole
UNII 554Z48XN5E - METHIMAZOLE

Thiamazole inhibits dose-dependently the incorporation of iodine into tyrosine and thereby the neosynthesis of thyroid hormones. This property permits symptomatic therapy of hyperthyroidism regardless of its cause.

Read about Thiamazole

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
H03BB02 Thiamazole H Systemic hormonal preparations, excl. Sex hormones and insulins → H03 Thyroid therapy → H03B Antithyroid preparations → H03BB Sulfur-containing imidazole derivatives
Discover more medicines within H03BB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 504104606112412, 504111401113411
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 5576-MAE-08-09
Country: MX Comisión Federal para la Protección contra Riesgos Sanitarios Identifier(s): 37373

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.